|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S.B. 281
|
|
2007 Vetoed Bills and Messages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(f) (1) The Medbank of Maryland, Inc. shall ensure that the Program is
available to residents in each of the following geographic regions of the State:
(i) Western Maryland;
(ii) The Eastern Shore;
(iii) The Baltimore metropolitan area;
(iv) The Maryland counties in the Washington, D.C.
metropolitan area; and
(v) Southern Maryland, including Anne Arundel County.
(2) Medbank of Maryland, Inc. shall be the central coordinating office
for the State.
(g) Eligibility for the Program shall be limited only by the criteria
established by pharmaceutical manufacturers for their patient assistance programs.
(h) (1) The Department shall require detailed financial reports at least
quarterly from Medbank of Maryland, Inc.
(2) The Medbank of Maryland, Inc. shall release funds to the entities
that operate the Program as needed and justified by the quarterly reports filed in
accordance with paragraph (1) of this subsection.
(i) On or before December 1, 2001, and annually thereafter, the Department
and Medbank of Maryland, Inc. shall report to the Governor and, in accordance with §
2-1246 of the State Government Article, to the General Assembly, on the status of the
Maryland Medbank Program established under this section, including:
(1) The number and demographic characteristics of the State residents
served by the Program;
(2) The types and retail value of prescription drugs accessed through
the Program;
(3) The nature and extent of outreach performed to inform State
residents of the assistance available through the Program; and
(4) The total volume and retail value of each brand name drug, by
manufacturer, accessed through the Program.
|
|
|
|
|
|
|
|
|
|
- 4192 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
